Matches in SemOpenAlex for { <https://semopenalex.org/work/W2319856125> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2319856125 abstract "Foretinib (formerly GSK1363089) is a small molecule multikinase inhibitor which includes inhibition of MET and VEGFR2. The ongoing phase II study, MET111643, is evaluating the safety and efficacy of 2 dosing schedules (continuous daily dosing and intermittent 5 days on/9 days off dosing) of foretinib as a single agent in pts with metastatic GC. An additional component of the study is to collect patient plasma samples before and during treatment with foretinib, to explore the potential pharmacodynamic effect and/or the modulation by foretinib of MET and VEGFR2. Plasma samples were collected from 42 pts on the intermittent 5 days on/9 off foretinib schedule at baseline and prior to dosing on days 5, 15, 29, and 47. The plasma levels of sMET, HGF, sVEGFR2, and VEGFA were measured using the Meso Scale Discovery platform (MSD). These marker changes from baseline were analyzed at each time point using analysis of variance and their relationships with plasma concentrations of foretinib (PK) and clinical outcome (progression free survival [PFS] and RECIST response) were also examined. Statistically significant increases from baseline of sMET at days 5, 15, 29, and 47 (p Changes in sMET, VEGFA, and sVEGFR2 levels were observed for both intermittent and daily dosing schedules in the gastric cancer study. Although SLD at 8 weeks did not change significantly from baseline in the GC study, plasma levels of sMET and VEGFA correlated positively with the week 8 magnitude of SLD. Hence plasma levels of sMET and VEGFA may reflect biological changes following foretinib treatment. Citation Information: Mol Cancer Ther 2009;8(12 Suppl):B210." @default.
- W2319856125 created "2016-06-24" @default.
- W2319856125 creator A5015668076 @default.
- W2319856125 creator A5046214153 @default.
- W2319856125 creator A5047485406 @default.
- W2319856125 creator A5070535554 @default.
- W2319856125 creator A5073773875 @default.
- W2319856125 creator A5079275603 @default.
- W2319856125 creator A5089202777 @default.
- W2319856125 creator A5091688844 @default.
- W2319856125 date "2009-12-10" @default.
- W2319856125 modified "2023-09-25" @default.
- W2319856125 title "Abstract B210: Shed MET (sMET), VEGFA, and sVEGFR2 are markers of foretinib treatment in metastatic gastric cancer patients" @default.
- W2319856125 doi "https://doi.org/10.1158/1535-7163.targ-09-b210" @default.
- W2319856125 hasPublicationYear "2009" @default.
- W2319856125 type Work @default.
- W2319856125 sameAs 2319856125 @default.
- W2319856125 citedByCount "1" @default.
- W2319856125 crossrefType "proceedings-article" @default.
- W2319856125 hasAuthorship W2319856125A5015668076 @default.
- W2319856125 hasAuthorship W2319856125A5046214153 @default.
- W2319856125 hasAuthorship W2319856125A5047485406 @default.
- W2319856125 hasAuthorship W2319856125A5070535554 @default.
- W2319856125 hasAuthorship W2319856125A5073773875 @default.
- W2319856125 hasAuthorship W2319856125A5079275603 @default.
- W2319856125 hasAuthorship W2319856125A5089202777 @default.
- W2319856125 hasAuthorship W2319856125A5091688844 @default.
- W2319856125 hasConcept C111113717 @default.
- W2319856125 hasConcept C112705442 @default.
- W2319856125 hasConcept C121608353 @default.
- W2319856125 hasConcept C126322002 @default.
- W2319856125 hasConcept C143998085 @default.
- W2319856125 hasConcept C2777288759 @default.
- W2319856125 hasConcept C71924100 @default.
- W2319856125 hasConcept C98274493 @default.
- W2319856125 hasConceptScore W2319856125C111113717 @default.
- W2319856125 hasConceptScore W2319856125C112705442 @default.
- W2319856125 hasConceptScore W2319856125C121608353 @default.
- W2319856125 hasConceptScore W2319856125C126322002 @default.
- W2319856125 hasConceptScore W2319856125C143998085 @default.
- W2319856125 hasConceptScore W2319856125C2777288759 @default.
- W2319856125 hasConceptScore W2319856125C71924100 @default.
- W2319856125 hasConceptScore W2319856125C98274493 @default.
- W2319856125 hasLocation W23198561251 @default.
- W2319856125 hasOpenAccess W2319856125 @default.
- W2319856125 hasPrimaryLocation W23198561251 @default.
- W2319856125 hasRelatedWork W1606977597 @default.
- W2319856125 hasRelatedWork W1960455028 @default.
- W2319856125 hasRelatedWork W1980111994 @default.
- W2319856125 hasRelatedWork W2002484960 @default.
- W2319856125 hasRelatedWork W2015093111 @default.
- W2319856125 hasRelatedWork W2065960304 @default.
- W2319856125 hasRelatedWork W2111005353 @default.
- W2319856125 hasRelatedWork W2127226854 @default.
- W2319856125 hasRelatedWork W2246054985 @default.
- W2319856125 hasRelatedWork W2259886307 @default.
- W2319856125 hasRelatedWork W2276093033 @default.
- W2319856125 hasRelatedWork W2278554093 @default.
- W2319856125 hasRelatedWork W2279180682 @default.
- W2319856125 hasRelatedWork W2332604050 @default.
- W2319856125 hasRelatedWork W2332623013 @default.
- W2319856125 hasRelatedWork W2466916381 @default.
- W2319856125 hasRelatedWork W2486846276 @default.
- W2319856125 hasRelatedWork W2592109135 @default.
- W2319856125 hasRelatedWork W2741056460 @default.
- W2319856125 hasRelatedWork W3011679583 @default.
- W2319856125 isParatext "false" @default.
- W2319856125 isRetracted "false" @default.
- W2319856125 magId "2319856125" @default.
- W2319856125 workType "article" @default.